These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9229573)

  • 21. Epithelial restitution and wound healing in inflammatory bowel disease.
    Sturm A; Dignass AU
    World J Gastroenterol; 2008 Jan; 14(3):348-53. PubMed ID: 18200658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs.
    Peura DA; Goldkind L
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S7-13. PubMed ID: 16168079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.
    Scheiman JM; Fendrick AM
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients.
    Zhang JT; Wang MW; Zhu ZL; Huo XH; Chu JK; Cui DS; Qiao L; Yu J
    World J Gastroenterol; 2005 Aug; 11(31):4918-22. PubMed ID: 16097073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism.
    Power JJ; Dennis MS; Redlak MJ; Miller TA
    Dig Dis Sci; 2004 Sep; 49(9):1518-25. PubMed ID: 15481331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
    Tavakoli M
    Pharmacoeconomics; 2003; 21(6):443-54. PubMed ID: 12678570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts.
    Williams CS; Sheng H; Brockman JA; Armandla R; Shao J; Washington MK; Elkahloun AG; DuBois RN
    Neoplasia; 2001; 3(5):428-36. PubMed ID: 11687954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori and NSAID gastropathy: an ambiguous association.
    Fendrick AM; Scheiman JM
    Curr Rheumatol Rep; 2001 Apr; 3(2):107-11. PubMed ID: 11286665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing NSAID Toxicity to the Upper Gastrointestinal Tract.
    Scheiman JM
    Curr Treat Options Gastroenterol; 1999 Jun; 2(3):205-213. PubMed ID: 11097721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats.
    Laudanno OM; Cesolari JA; Esnarriaga J; San Miguel P; Bedini OA
    Dig Dis Sci; 2000 Jul; 45(7):1359-65. PubMed ID: 10961715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we make any recommendations about physical activity and peptic ulcer disease?
    Strom E
    West J Med; 2000 Aug; 173(2):108-9. PubMed ID: 10924431
    [No Abstract]   [Full Text] [Related]  

  • 32. Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion.
    Devor DC; Schultz BD
    J Clin Invest; 1998 Aug; 102(4):679-87. PubMed ID: 9710435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin use and potential mechanisms for colorectal cancer prevention.
    Williams CS; Smalley W; DuBois RN
    J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention.
    Rich M; Scheiman JM
    Semin Arthritis Rheum; 2000 Dec; 30(3):167-79. PubMed ID: 11124281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drugs: how do they damage the gut?
    Levi S; Shaw-Smith C
    Br J Rheumatol; 1994 Jul; 33(7):605-12. PubMed ID: 8019787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal effects of NSAIDs. Difficulties in detection and management.
    Pearson SP; Kelberman I
    Postgrad Med; 1996 Nov; 100(5):131-2, 135-6, 141-3. PubMed ID: 8917329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.
    Scarpignato C; Hunt RH
    Gastroenterol Clin North Am; 2010 Sep; 39(3):433-64. PubMed ID: 20951911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSAIDs, gastrointestinal injury, and cytoprotection.
    Scheiman JM
    Gastroenterol Clin North Am; 1996 Jun; 25(2):279-98. PubMed ID: 9229573
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.